Skip to content
10-K

Annual Report

EIDOS THERAPEUTICS, INC.

0001564590-20-006823

← back to feed
Filed
Feb 26, 2020 12:00 AM ET
Period of report
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding FY 2019 · Feb 24, 2020 38.51M sh
Shares Diluted FY 2019 · Dec 31, 2019 37.11M sh
Shares Diluted FY 2019 · Dec 31, 2018 22.04M sh
Shares Diluted FY 2019 · Dec 31, 2017 4.32M sh
Capex FY 2019 · Dec 31, 2019 $227K
Capex FY 2019 · Dec 31, 2018 $150K
Capex FY 2019 · Dec 31, 2017 $53K
Operating Cash Flow FY 2019 · Dec 31, 2019 −$31.65M
Operating Cash Flow restated FY 2019 · Dec 31, 2018 −$33.3M
Operating Cash Flow FY 2019 · Dec 31, 2017 −$9.72M
Long Term Debt FY 2019 · Dec 31, 2019 $16.11M
Cash And Equivalents FY 2019 · Dec 31, 2019 $191.16M
Cash And Equivalents FY 2019 · Dec 31, 2018 $157.15M
Cash And Equivalents FY 2019 · Dec 31, 2017 $5.5M
Cash And Equivalents FY 2019 · Dec 31, 2016 $1.96M
Stockholders Equity FY 2019 · Dec 31, 2019 $171.43M
Stockholders Equity FY 2019 · Dec 31, 2018 $155.01M
Stockholders Equity FY 2019 · Dec 31, 2017 −$13.2M
Stockholders Equity FY 2019 · Dec 31, 2016 −$2.47M
Current Liabilities FY 2019 · Dec 31, 2019 $10.43M
Current Liabilities FY 2019 · Dec 31, 2018 $4.79M
Total Liabilities FY 2019 · Dec 31, 2019 $32.39M
Total Liabilities FY 2019 · Dec 31, 2018 $5.11M
Current Assets FY 2019 · Dec 31, 2019 $195.92M
Current Assets FY 2019 · Dec 31, 2018 $158.97M
Total Assets FY 2019 · Dec 31, 2019 $203.82M
Total Assets FY 2019 · Dec 31, 2018 $160.11M
Eps Diluted FY 2019 · Dec 31, 2019 −$0.51
Eps Diluted FY 2019 · Sep 30, 2019 $0.18
Eps Diluted FY 2019 · Jun 30, 2019 −$0.39
Eps Diluted FY 2019 · Mar 31, 2019 −$0.32
Eps Basic FY 2019 · Dec 31, 2019 −$0.51
Eps Basic FY 2019 · Sep 30, 2019 $0.19
Eps Basic FY 2019 · Jun 30, 2019 −$0.39
Eps Basic FY 2019 · Mar 31, 2019 −$0.32
Sga Expense FY 2019 · Dec 31, 2019 $17.75M
Sga Expense FY 2019 · Dec 31, 2018 $9.24M
Sga Expense FY 2019 · Dec 31, 2017 $2.73M
Rd Expense FY 2019 · Dec 31, 2019 $46.89M
Rd Expense FY 2019 · Dec 31, 2018 $28.54M
Rd Expense FY 2019 · Dec 31, 2017 $9.29M
Net Income FY 2019 · Dec 31, 2019 −$37.84M
Net Income FY 2019 · Dec 31, 2018 −$40.73M
Net Income FY 2019 · Dec 31, 2017 −$11.94M
Operating Income FY 2019 · Dec 31, 2019 −$19.32M
Operating Income FY 2019 · Dec 31, 2019 −$40.45M
Operating Income FY 2019 · Sep 30, 2019 $6.25M
Operating Income FY 2019 · Jun 30, 2019 −$14.79M
Operating Income FY 2019 · Mar 31, 2019 −$12.58M
Operating Income FY 2019 · Dec 31, 2018 −$10.71M
Operating Income FY 2019 · Dec 31, 2018 −$37.78M
Operating Income FY 2019 · Sep 30, 2018 −$10.99M
Operating Income FY 2019 · Jun 30, 2018 −$8.09M
Operating Income FY 2019 · Mar 31, 2018 −$8M
Operating Income FY 2019 · Dec 31, 2017 −$12.02M
Cost Of Revenue FY 2019 · Dec 31, 2019 $2.5M
Revenue FY 2019 · Dec 31, 2019 $26.69M